MedTrace Logo

NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia

NCT00833456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2011-10-14

No results posted yet for this study

Summary

The purpose of the study is to monitor the general functional changes among patients with schizophrenia, treated with atypical antipsychotics dosed once daily for a period of 6 months.The primary study objective is to compare general functioning of patients with schizophrenia treated with Seroquel SR between baseline and the last study visit. The secondary study objectives are to compare general functioning of patients with schizophrenia treated with other atypical antipsychotic medicinal products administered once daily between baseline and the last study visit, monitoring of other indicators of clinical improvement, evaluation of patient compliance and assessment of occurrence of adverse effects

Conditions

Sponsors & Collaborators

Principal Investigators

  • Peter Pregelj, MD, PhD · Psihiatricna klinika Ljubljana, Studenec 48, 1260 Ljubljana

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00833456 on ClinicalTrials.gov